Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Core Insights - Analysts project Agilent Technologies will report quarterly earnings of $1.59 per share, an increase of 8.9% year over year, with revenues expected to reach $1.83 billion, up 7.8% from the same quarter last year [1] Revenue Estimates - Net Revenue from the Life Sciences and Diagnostics Markets Segment is estimated at $728.07 million, reflecting a year-over-year decline of 12.6% [4] - Net Revenue from the Agilent Crosslab Group is projected to be $750.83 million, indicating a significant increase of 76.3% year over year [4] - Revenue from the Chemical and Advanced Materials end market is expected to reach $410.16 million, showing a growth of 6.5% from the prior-year quarter [5] - Revenue from the Environmental and Forensics end market is forecasted at $180.82 million, representing a 10.3% increase from the prior-year quarter [5] - Revenue from the Diagnostics and Clinical end market is estimated at $266.56 million, indicating a year-over-year growth of 4.5% [6] - Revenue from the Academia and Government end market is projected to be $158.45 million, reflecting a change of 5.6% from the prior-year quarter [6] - Revenue from the Pharmaceutical end market is expected to reach $645.74 million, indicating an increase of 8.5% from the prior-year quarter [7] - Revenue from the Food end market is projected at $164.74 million, reflecting an increase of 8.4% from the prior-year quarter [7] Market Performance - Agilent shares have shown a return of -1.3% over the past month, compared to a -0.6% change in the Zacks S&P 500 composite [7] - Agilent holds a Zacks Rank 3 (Hold), suggesting it is expected to mirror overall market performance in the near future [7]